These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21091887)

  • 21. Vascular and Chronological Age in Subjects with Erectile Dysfunction: A Cross-Sectional Study.
    Rastrelli G; Corona G; Mannucci E; Maggi M
    J Sex Med; 2015 Dec; 12(12):2303-12. PubMed ID: 26632075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors.
    Rastrelli G; Corona G; Lotti F; Aversa A; Bartolini M; Mancini M; Mannucci E; Maggi M
    J Sex Med; 2014 Jan; 11(1):173-86. PubMed ID: 24433560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials.
    Winkler K; Ablethauser CB; Gimpelewicz C; Bortolini M; Isaacsohn JL
    Clin Ther; 2007 Sep; 29(9):1987-2000. PubMed ID: 18035198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulse pressure independently predicts major cardiovascular events in younger but not in older subjects with erectile dysfunction.
    Corona G; Monami M; Boddi V; Rastrelli G; Melani C; Balzi D; Sforza A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2011 Jan; 8(1):247-54. PubMed ID: 20722787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomere length as a marker of cellular aging is associated with prevalence and progression of metabolic syndrome.
    Révész D; Milaneschi Y; Verhoeven JE; Penninx BW
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4607-15. PubMed ID: 25188715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunction.
    Corona G; Rastrelli G; Monami M; Melani C; Balzi D; Sforza A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2011 Jul; 8(7):2098-105. PubMed ID: 21561538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome and its individual components with mortality among patients with coronary heart disease.
    Chen Q; Zhang Y; Ding D; Li D; Xia M; Li X; Yang Y; Li Q; Hu G; Ling W
    Int J Cardiol; 2016 Dec; 224():8-14. PubMed ID: 27599384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are all metabolic syndrome components responsible for penile hemodynamics impairment in patients with erectile dysfunction? The role of body fat mass assessment.
    Tomada N; Tomada I; Botelho F; Cruz F; Vendeira P
    J Sex Med; 2011 Mar; 8(3):831-9. PubMed ID: 21091885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome: a potential and independent risk factor for erectile dysfunction in the Chinese male population.
    Chen K; Mi H; Gao Y; Tan A; Lu Z; Wu C; Liao M; Zhang Y; Mo Z
    Urology; 2012 Dec; 80(6):1287-92. PubMed ID: 23040724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
    Suadicani P; Hein HO; Gyntelberg F
    Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolic syndrome, incidence of diabetes and mortality among the elderly: the Italian Longitudinal Study of Ageing.
    Noale M; Maggi S; Zanoni S; Limongi F; Zambon S; Crepaldi G;
    Diabetes Metab; 2012 Apr; 38(2):135-41. PubMed ID: 22071281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk.
    Salazar MR; Carbajal HA; Espeche WG; Dulbecco CA; Aizpurúa M; Marillet AG; Echeverría RF; Reaven GM
    Diab Vasc Dis Res; 2011 Apr; 8(2):109-16. PubMed ID: 21562062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study.
    Raffaitin C; Gin H; Empana JP; Helmer C; Berr C; Tzourio C; Portet F; Dartigues JF; Alpérovitch A; Barberger-Gateau P
    Diabetes Care; 2009 Jan; 32(1):169-74. PubMed ID: 18945929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of non-HDL cholesterol with the presence of metabolic syndrome in North Indian subjects with and without CAD.
    Garg PR; Kabita S; Sinha E; Kalla L; Kaur L; Saraswathy KN
    Ann Hum Biol; 2013 Jan; 40(1):111-5. PubMed ID: 23198906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
    J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indicators of Cardiovascular Risk in Metabolic Syndrome: Long Term Follow-up in Italian Patients.
    Mombelli G; Pavanello C; Castelnuovo S; Bosisio R; Simonelli S; Pazzucconi F; Sirtori CR
    Curr Vasc Pharmacol; 2017; 15(3):248-256. PubMed ID: 28128067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activity.
    Papadakis JA; Sidiropoulos PI; Karvounaris SA; Vrentzos GE; Spanakis EK; Ganotakis ES; Kritikos HD; Mikhailidis DP; Boumpas DT
    Clin Exp Rheumatol; 2009; 27(2):292-8. PubMed ID: 19473571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.